Guillaume Pfefer, Sail Biomedicines CEO
October 19, 2023 11:33 AM EDTUpdated 01:52 PM
Startups

Up­dat­ed: Flag­ship merges its trou­bled cir­cu­lar RNA com­pa­ny Laronde with nanopar­ti­cle start­up Sen­da

Ryan Cross

Senior Science Correspondent

Laronde and Sen­da Bio­sciences, two biotech star­tups found­ed by Flag­ship Pi­o­neer­ing that col­lec­tive­ly raised more than $750 mil­lion, are merg­ing to form a new com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times